In the latest market close, Harte-Hanks (HHS) reached $8.44, with a +0.24% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 1.08% for the day. Meanwhile, the Dow experienced a rise of 0.75%, and the technology-dominated Nasdaq saw an increase of 2.64%. The the stock of marketing company has fallen by 2.66% in the past month, lagging the Business Services sector's loss of 0.69% and the S&P 500's loss of 0.44%. The upcoming earnings release of Harte-Hanks ...

Harte-Hanks (HHS) closed at $8.40 in the latest trading session, marking a -0.94% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.08%. At the same time, the Dow lost 0.12%, and the tech-heavy Nasdaq gained 0.07%. Market participants will be closely following the financial results of Harte-Hanks in its upcoming release. The company plans to announce its earnings on August 8, 2024. The company is predicted to post an EPS of $0.06, indicating a 25% decline compared to ...

Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits. One company to watch right now is Harte Hanks (HHS) . HHS is currently sporting a Zacks Rank of #1 (Strong Buy) and an A for Value. The stock is trading with a P/E ratio of 8.03, which comp ...

Core Viewpoint - Harte-Hanks (HHS) has reached a significant support level and shows potential for investors from a technical perspective, with a recent breakthrough of the 20-day moving average indicating a short-term bullish trend [1][2] Technical Analysis - HHS broke through the 20-day moving average, which is a popular trading tool that reflects a stock's price over a 20-day period, smoothing out short-term price trends and providing trend reversal signals [1] - A stock price above the 20-day moving average indicates a positive trend, while a price below suggests a downward trend [1] Performance Metrics - Shares of HHS have increased by 7.4% over the past four weeks [2] - HHS is currently rated as a Zacks Rank 1 (Strong Buy), indicating potential for continued price appreciation [2] Earnings Estimates - There have been positive earnings estimate revisions for HHS, with no estimates decreasing in the past two months and two estimates increasing, leading to a rise in the consensus estimate [2] - The combination of the technical indicator and positive earnings revisions suggests that HHS should be considered for a watchlist by investors [2]

This marketing company is expected to post quarterly earnings of $0.09 per share in its upcoming report, which represents a year-over-year change of +12.5%. Revenues are expected to be $46.6 million, down 2.4% from the year-ago quarter. The stock currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> The stock is gaining from the Elevate program that improves the company's agility, innovation, organic growth and customer centricit ...

Here are three stocks with buy rank and strong value characteristics for investors to consider today, June 27th: Macy's (M) : This omni-channel retail organization which operates stores, websites, and mobile applications in the United States, carries a Zacks Rank #1(Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.6% over the last 60 days. Macy's has a price-to-earnings ratio (P/E) of 6.83 compared with 12.10 for the industry. The company possesses a Val ...

The investment community will be paying close attention to the earnings performance of Harte-Hanks in its upcoming release. The company's earnings per share (EPS) are projected to be $0.09, reflecting a 12.5% increase from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $46.6 million, showing a 2.43% drop compared to the year-ago quarter. Harte-Hanks (HHS) closed at $7.57 in the latest trading session, marking a -0.26% move from the prior day. This change ...

The most recent trading session ended with Harte-Hanks (HHS) standing at $7.64, reflecting a -1.67% shift from the previouse trading day's closing. The stock trailed the S&P 500, which registered a daily gain of 0.77%. Elsewhere, the Dow gained 0.49%, while the tech-heavy Nasdaq added 0.95%. Coming into today, shares of the marketing company had gained 2.51% in the past month. In that same time, the Business Services sector lost 0.77%, while the S&P 500 gained 3.71%. Market participants will be closely foll ...

Core Viewpoint - The article emphasizes the importance of identifying stocks with strong fundamentals and positive earnings revisions to sustain price momentum, particularly highlighting Harte-Hanks (HHS) as a potential investment opportunity. Group 1: Stock Performance - HHS has experienced a solid price increase of 3.1% over the past 12 weeks, indicating investor willingness to pay more for its potential upside [2] - Currently, HHS is trading at 92.3% of its 52-week high-low range, suggesting it may be on the verge of a breakout [3] - A price increase of 2.5% over the past four weeks confirms that the upward price trend for HHS is still intact [8] Group 2: Investment Strategy - The "Recent Price Strength" screen is a useful tool for identifying stocks with sufficient fundamental strength to maintain their recent uptrend, filtering stocks that are trading in the upper portion of their 52-week range [7] - The Zacks Rank stock-rating system classifies stocks based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988, indicating a strong track record for successful stock-picking [9] - HHS currently holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [10] Group 3: Analyst Recommendations - The average broker recommendation for HHS is 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [13] - In addition to HHS, there are several other stocks that meet the criteria of the "Recent Price Strength" screen, suggesting further investment opportunities [11]

Harte-Hanks (HHS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years. Individual inv ...